Don't miss more helpful resources about Boston Scientific’s Drug-Eluting Technologies in the Resources Center and join the Drug Eluting Technology Community to receive the latest news of Drug Eluting Technologies.

Boston Scientific is revolutionizing the field of drug-eluting therapies with the most complete portfolio of technologies.

Watch experts deploy the Eluvia DES and Ranger DCB to treat a polystenotic calcified SFA lesion in a 75-year-old male patient.

The video shows the diagnostic work-up with antegrade infusion, which finds a heavily diseased right SFA and short sub-total occlusion of an existing stent.
January 18, 2017
About Drug-Eluting Technologies
Clinical Program
Resources Center
News & Events


Join our Drug-Eluting Technologies Community

Sign Up for Product Updates

Receive the latest news of Drug Eluting Technologies